aminolevulinic acid has been researched along with Adult-Onset Still Disease in 1 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sumiyoshi, R | 1 |
| Koga, T | 1 |
| Shimizu, T | 1 |
| Sato, S | 1 |
| Tashiro, S | 1 |
| Hosogaya, N | 1 |
| Yamamoto, H | 1 |
| Kawakami, A | 1 |
1 trial available for aminolevulinic acid and Adult-Onset Still Disease
| Article | Year |
|---|---|
Single-arm, open-label pilot intervention study to investigate an effect of oral 5-aminolevulinic acid plus sodium ferrous citrate on glucocorticoid reduction in patients with adult-onset Still disease: Study protocol for clinical trial (SPIRIT compliant)
Topics: Administration, Oral; Adult; Aminolevulinic Acid; Citric Acid; Drug Therapy, Combination; Female; Fe | 2020 |